Your browser doesn't support javascript.
loading
From class waivers to precision medicine in paediatric oncology.
Pearson, Andrew D J; Pfister, Stefan M; Baruchel, Andre; Bourquin, Jean-Pierre; Casanova, Michela; Chesler, Louis; Doz, François; Eggert, Angelika; Geoerger, Birgit; Jones, David T W; Kearns, Pamela R; Molenaar, Jan J; Morland, Bruce; Schleiermacher, Gudrun; Schulte, Johannes H; Vormoor, Josef; Marshall, Lynley V; Zwaan, C Michel; Vassal, Gilles.
Afiliación
  • Pearson ADJ; Paediatric Drug Development, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK; Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK. Electronic address: andy1pearson@btinternet.com.
  • Pfister SM; Division of Pediatric Neuro-oncology, German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Baruchel A; Pediatric Hematology-Immunology Department, University Hospital Robert Debré and Paris Diderot University, Paris, France.
  • Bourquin JP; Division of Oncology and Hematology, University Children's Hospital Zurich, Children's Research Center, Zurich, Switzerland.
  • Casanova M; Paediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Chesler L; Paediatric Drug Development, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK; Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.
  • Doz F; Department of Paediatric, Adolescents and Young Adults Oncology and INSERM U830, Institut Curie, Paris, France.
  • Eggert A; Department of Pediatric Oncology and Hematology, Charité University Hospital, Berlin, Germany; German Cancer Consortium, Berlin, Germany; Berlin Institute of Health, Berlin, Germany.
  • Geoerger B; Department of Pediatric and Adolescent Oncology, CNRS UMR 8203 Vectorology and Anticancer Treatments, Gustave Roussy, Université Paris-Sud, Villejuif, France.
  • Jones DTW; Division of Pediatric Neuro-oncology, German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Heidelberg, Germany.
  • Kearns PR; Cancer Research UK Clinical Trials Unit Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Molenaar JJ; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Morland B; Department of Paediatric Oncology, Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Schleiermacher G; Department of Paediatric, Adolescents and Young Adults Oncology and INSERM U830, Institut Curie, Paris, France.
  • Schulte JH; Department of Pediatric Oncology and Hematology, Charité University Hospital, Berlin, Germany; German Cancer Consortium, Berlin, Germany; Berlin Institute of Health, Berlin, Germany.
  • Vormoor J; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University and Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Marshall LV; Paediatric Drug Development, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK; Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.
  • Zwaan CM; Department of Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Vassal G; Department of Clinical Research, Gustave Roussy, Paris-Sud University, Paris, France.
Lancet Oncol ; 18(7): e394-e404, 2017 07.
Article en En | MEDLINE | ID: mdl-28677575
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Medicina de Precisión / Legislación de Medicamentos / Neoplasias / Antineoplásicos Límite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Medicina de Precisión / Legislación de Medicamentos / Neoplasias / Antineoplásicos Límite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article